The company in question is, Merck & Co., Inc. (NYSE:MRK) currently with a stock price of 62.58 (-2.00% today). The market cap for Merck & Co., Inc. is 178263.28, and is in the sector Healthcare, and Drug Manufacturers – Major industry. The target price for Merck & Co., Inc. is *TBA. Currently Merck & Co., Inc. is trading with a P/E of 34.97, and a forward P/E of 17.01. Average volume for Merck & Co., Inc. is 9619.11 and so far today it is 14704910.
Performance in the last year for Merck & Co., Inc. has been 13.08%. For EPS growth, Merck & Co., Inc. has seen a growth of -61.60%, and is looking to grow in the next year to 0.59%. More long term stats show that EPS growth has been 41.50% over the last five years and could be 5.35% for the next five years. Merck & Co., Inc. has seen sales growth quarter over quarter at 0.60%, with EPS growth quarter over quarter at 79.20%. The 20-day simple moving average is 8.49%, with the 200-day simple moving average coming to 16.76%.
Since the IPO date for Merck & Co., Inc. on the 1/2/1970, Merck & Co., Inc. has seen performance year to date to be 22.95%. With Merck & Co., Inc. trading at 62.58, the dividend yield is 2.88%, and the EPS is 1.83.
So could Merck & Co., Inc., be undervalued? Well as said before P/E is 34.97. The PEG is 6.53, P/S is 4.52 and the P/B is at 4.04. The P/cash is *TBA, with P/free cash flow at *TBA.
Merck & Co., Inc. ability to deal with debt shows that the current ratio is *TBA, and the quick ratio is *TBA. This is with long term debt/equity at *TBA, and total debt/equity at *TBA.
In terms of margins, Merck & Co., Inc. has a gross margin of 63.10%, an operating margin of 18.10% and a profit margin of 13.00%.Payout ratio for Merck & Co., Inc. is 74.60%. Return on assets come to *TBA with return on investment coming to 6.40%.
Insider ownership for Merck & Co., Inc., is at 0.04% and institutional ownership comes to 75.00%. Outstanding shares are at 2791.47. While shares float is 2766.95. The float short is currently 1.16%, and short ratio is 3.33.